CX Institutional Purchases 2,185 Shares of HCA Healthcare, Inc. (NYSE:HCA)

CX Institutional lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 16.2% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 15,707 shares of the company’s stock after acquiring an additional 2,185 shares during the quarter. CX Institutional’s holdings in HCA Healthcare were worth $4,715,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Benjamin F. Edwards & Company Inc. bought a new position in shares of HCA Healthcare during the 2nd quarter worth $33,000. Legacy Investment Solutions LLC acquired a new stake in HCA Healthcare in the 3rd quarter worth about $39,000. Canoe Financial LP purchased a new stake in shares of HCA Healthcare during the third quarter worth $41,000. Capital Performance Advisors LLP acquired a new position in shares of HCA Healthcare during the 3rd quarter valued at about $41,000. Finally, Northwest Investment Counselors LLC purchased a new stake in shares of HCA Healthcare in the 3rd quarter valued at $44,000. 62.73% of the stock is owned by institutional investors.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. This trade represents a 6.89 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a report on Tuesday, December 17th. Barclays reduced their price objective on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research report on Friday, November 8th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. Morgan Stanley cut their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. Finally, TD Cowen decreased their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $385.27.

HCA Healthcare Price Performance

NYSE HCA opened at $322.29 on Friday. HCA Healthcare, Inc. has a twelve month low of $279.93 and a twelve month high of $417.14. The stock has a market capitalization of $81.64 billion, a PE ratio of 14.45, a P/E/G ratio of 1.09 and a beta of 1.64. The stock has a 50-day simple moving average of $314.50 and a 200 day simple moving average of $352.84. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.52% and a return on equity of 520.98%. During the same period in the previous year, the company earned $5.90 earnings per share. Research analysts anticipate that HCA Healthcare, Inc. will post 21.75 EPS for the current year.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.